These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10196008)

  • 1. Blood pressure, antihypertensive medication, and atherosclerotic renal artery stenosis.
    Tullis MJ; Caps MT; Zierler RE; Bergelin RO; Polissar N; Cantwell-Gab K; Davidson RC; Strandness DE
    Am J Kidney Dis; 1999 Apr; 33(4):675-81. PubMed ID: 10196008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and duplex ultrasound follow-up after balloon angioplasty for atherosclerotic renal artery stenosis.
    Morellato C; Bergelin RO; Cantwell-Gab K; Zierler RE; Polissar NL; Davidson RC; Strandness DE
    Vasc Surg; 2001; 35(2):85-93. PubMed ID: 11668375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of long-term beneficial effects on blood pressure after percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis.
    Alhadad A; Mattiasson I; Ivancev K; Lindblad B; Gottsäter A
    Int Angiol; 2009 Apr; 28(2):106-12. PubMed ID: 19367240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic repair of renal artery stenosis is not justified in patients who require infrarenal aortic reconstruction.
    Williamson WK; Abou-Zamzam AM; Moneta GL; Yeager RA; Edwards JM; Taylor LM; Porter JM
    J Vasc Surg; 1998 Jul; 28(1):14-20; discussion 20-2. PubMed ID: 9685126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group.
    van Jaarsveld BC; Krijnen P; Pieterman H; Derkx FH; Deinum J; Postma CT; Dees A; Woittiez AJ; Bartelink AK; Man in 't Veld AJ; Schalekamp MA
    N Engl J Med; 2000 Apr; 342(14):1007-14. PubMed ID: 10749962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitor usage in patients with incidental atherosclerotic renal artery stenosis.
    Yang JG; Hu D; Li T; Peng J; Yu H; Pang W; Wang C; Xiao J; Xu Y
    Hypertens Res; 2004 May; 27(5):339-44. PubMed ID: 15198481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evidence of contralateral renal parenchymal injury in patients with unilateral atherosclerotic renal artery stenosis.
    Tullis MJ; Zierler RE; Caps MT; Bergelin RO; Cantwell-Gab K; Strandness DE
    Ann Vasc Surg; 1998 Mar; 12(2):122-7. PubMed ID: 9514228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis.
    Caps MT; Zierler RE; Polissar NL; Bergelin RO; Beach KW; Cantwell-Gab K; Casadei A; Davidson RC; Strandness DE
    Kidney Int; 1998 Mar; 53(3):735-42. PubMed ID: 9507221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The changing etiology and therapeutic situation of atherosclerotic renal artery stenosis].
    Wang F; Wang M; Liu YC; Wang HY
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2762-6. PubMed ID: 16324317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease.
    Deshmukh H; Barker E; Anbarasan T; Levin D; Bell S; Witham MD; George J
    Cardiovasc Ther; 2018 Dec; 36(6):e12474. PubMed ID: 30372589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal artery pressure gradients in patients with angiographic evidence of atherosclerotic renal artery stenosis.
    Nahman NS; Maniam P; Hernandez RA; Falkenhain M; Hebert LA; Kantor BS; Stockum AE; VanAman ME; Spigos DG
    Am J Kidney Dis; 1994 Oct; 24(4):695-9. PubMed ID: 7942830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors for restenosis, and its impact on blood pressure control after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis.
    Iwashima Y; Fukuda T; Yoshihara F; Kusunoki H; Kishida M; Hayashi S; Nakamura S; Kamide K; Horio T; Kawano Y
    J Hypertens; 2016 Jul; 34(7):1407-15. PubMed ID: 27065003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Hypertensive Patients with Renal Fibromuscular Dysplasia Compared with Patients with Concomitant Atherosclerotic Renal Artery Stenosis following Endovascular Therapy.
    Jenkins TL; Baker MG; Baheti AR; Sharma AM; Patrie JT; Angle JF; Matsumoto AH
    J Vasc Interv Radiol; 2015 May; 26(5):625-33; quiz 634. PubMed ID: 25921452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design.
    Bax L; Mali WP; Buskens E; Koomans HA; Beutler JJ; Braam B; Beek FJ; Rabelink TJ; Postma CT; Huysmans FT; Deinum J; Thien T; Schultze Kool LJ; Woittiez AJ; Kouwenberg JJ; van den Meiracker AH; Pattynama PM; van de Ven PJ; Vroegindeweij D; Doorenbos CJ; Aarts JC; Kroon AA; de Leeuw PW; de Haan MW; van Engelshoven JM; Rutten MJ; van Montfrans GA; Reekers JA; Plouin PF; La Batide Alanore A; Azizi M; Raynaud A; Harden PN; Cowling M;
    J Nephrol; 2003; 16(6):807-12. PubMed ID: 14736007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of atherosclerotic disease progression in the renal artery.
    Caps MT; Perissinotto C; Zierler RE; Polissar NL; Bergelin RO; Tullis MJ; Cantwell-Gab K; Davidson RC; Strandness DE
    Circulation; 1998 Dec 22-29; 98(25):2866-72. PubMed ID: 9860789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Percutaneous Transluminal Renal Angioplasty on Office and Home Blood Pressure and Home Blood Pressure Variability in Hypertensive Patients With Renal Artery Stenosis.
    Iwashima Y; Fukuda T; Kusunoki H; Hayashi SI; Kishida M; Yoshihara F; Nakamura S; Kamide K; Horio T; Kawano Y
    Hypertension; 2017 Jan; 69(1):109-117. PubMed ID: 27872233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of patients with atherosclerotic renal artery disease.
    Safak E; Wilke C; Derer W; Busjahn A; Gross M; Moeckel M; Mueller DN; Luft FC; Dechend R
    J Am Soc Hypertens; 2013; 7(1):24-31. PubMed ID: 23321402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerotic renal artery stenosis: update on management strategies.
    Meier P
    Curr Opin Cardiol; 2011 Nov; 26(6):463-71. PubMed ID: 21799405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.
    Jaff MR; Bates M; Sullivan T; Popma J; Gao X; Zaugg M; Verta P;
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):343-50. PubMed ID: 22511402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease.
    van de Ven PJ; Beutler JJ; Kaatee R; Beek FJ; Mali WP; Koomans HA
    Kidney Int; 1998 Apr; 53(4):986-93. PubMed ID: 9551408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.